Skip to main content

Table 1 Characteristics of patients with a newly diagnosed esophageal or gastric cancer, by different waiting time groups

From: Waiting time for cancer treatment and mental health among patients with newly diagnosed esophageal or gastric cancer: a nationwide cohort study

Characteristics

All

Waiting time groups

1–8 days

9–17 days

18–29 days

30–60 days

>60 days

Number of patients

7080

1733

1542

1556

1601

648

Demographic factors

Age, mean ± SD, years

71.4 ± 11.9

73.7 ± 12.5

70.4 ± 12.2

70.4 ± 11.6

71.1 ± 11.1

70.3 ± 11.1

Gender (% male)

65.7

63.1

67.1

66.3

65.5

69.0

 Material status, n (%)

  Single

914 (12.9)

235 (13.6)

227 (14.7)

180 (11.6)

189 (11.8)

83 (12.8)

  Married

3626 (51.2)

797 (46.0)

806 (52.3)

843 (54.2)

842 (52.6)

338 (52.2)

  Divorce

1158 (16.4)

284 (16.4)

236 (15.3)

242 (15.6)

284 (17.7)

112 (17.3)

  Widow/widower

1368 (19.3)

411 (23.7)

271 (17.6)

288 (18.5)

283 (17.7)

115 (17.8)

  Missing

14 (0.2)

6 (0.3)

2 (0.1)

3 (0.2)

3 (0.2)

0 (0.0)

 Education level, n (%)

   < =9 years

3070 (43.4)

778 (44.9)

655 (42.5)

643 (41.3)

700 (43.7)

294 (45.4)

  10–12 years

2561 (36.2)

586 (33.8)

545 (35.3)

578 (37.2)

600 (37.5)

252 (38.9)

   > =12 years

1038 (14.7)

227 (13.1)

239 (15.5)

255 (16.4)

235 (14.7)

82 (12.7)

  Missing

411 (5.8)

142 (8.2)

103 (6.7)

80 (5.1)

66 (4.1)

20 (3.1)

Disease-related factors

 Time of follow-up (months, until death, emigration or the end of study)

  Mean ± SD

15.6 ± 18.0

10.4 ± 16.1

13.0 ± 15.8

16.3 ± 17.7

18.5 ± 18.0

26.6 ± 21.5

  Hospital Volume

      

  Low (<20 cases/year)

3310 (46.8)

975 (56.3)

749 (48.6)

664 (42.7)

659 (41.2)

263 (40.5)

  Median (20–40 cases/year)

1868 (26.4)

442 (25.5)

456 (29.5)

420 (27.0)

387 (24.1)

163 (25.2)

  High (>40 cases/year)

1899 (26.8)

314 (18.1)

337 (21.9)

471 (30.3)

555 (34.7)

222 (34.3)

  Missing

2 (0.0)

0 (0.0)

1 (0.0)

0 (0.0)

0 (0.0)

3 (0.0)

 ASA physical status, n (%)

  I-II

4319 (61.0)

902 (52.1)

970 (62.9)

1023 (65.8)

1030 (64.3)

394 (60.7)

  III-IV

2588 (36.6)

791 (45.6)

529 (34.3)

494 (31.8)

539 (33.7)

235 (36.3)

  Missing

173 (2.4)

40 (2.3)

43 (2.8)

39 (2.4)

32 (2.0)

19 (2.9)

 Cancer type, n (%)

  Gastric cancer

3562 (50.3)

1004 (57.9)

788 (51.1)

737 (47.4)

715 (44.7)

318 (49.1)

  Esophageal cancer

3518 (49.7)

729 (42.1)

754 (48.9)

819 (52.6)

886 (55.3)

330 (50.9)

 Cancer stage, n (%)

  Stage 0

191 (2.70)

24 (1.38)

24 (1.56)

29 (1.86)

52 (3.25)

62 (9.57)

  Stage I

905 (12.8)

131 (7.56)

157 (10.2)

226 (14.5)

260 (16.2)

131 (20.2)

  Stage II

924 (13.1)

155 (8.94)

200 (13.0)

252 (16.2)

236 (14.7)

81 (12.5)

  Stage III

2824 (39.9)

688 (39.7)

601 (39.0)

615 (39.5)

671 (41.9)

249 (38.4)

  Stage IV

2188 (30.9)

726 (41.9)

557 (36.1)

423 (27.2)

369 (23.1)

113 (17.4)

  Missing

48 (0.7)

9 (0.5)

3 (0.2)

11 (0.7)

13 (0.8)

12 (1.9)

 Admission type, n (%)

  GP referral

5406 (76.4)

1071 (61.8)

1128 (73.2)

1303 (83.7)

1367 (85.4)

537 (82.9)

  Emergency intake

1517 (21.4)

627 (36.2)

367 (23.8)

225 (14.5)

201 (12.6)

97 (15.0)

  Missing

157 (2.2)

35 (2.0)

47 (3.0)

28 (1.8)

33 (2.0)

14 (2.1)

 Treatment decided through multidisciplinary conference, n (%)

  Yes

4080 (57.6)

668 (38.6)

929 (60.3)

990 (63.6)

1074 (67.1)

419 (64.7)

  No

2953 (41.7)

1053 (60.8)

599 (38.9)

556 (35.7)

521 (32.5)

224 (34.6)

  Missing

47 (0.7)

12 (0.6)

14 (0.8)

10 (0.7)

6 (0.4)

5 (0.7)

 Planned treatment type, n (%)

  Curative

3038 (42.9)

484 (27.9)

607 (39.4)

783 (50.3)

824 (51.5)

340 (52.5)

  Palliative

2631 (37.2)

714 (41.2)

663 (43.0)

547 (35.2)

548 (34.2)

159 (24.5)

  Supportive

1400 (19.8)

531 (30.6)

271 (17.6)

226 (14.5)

227 (14.2)

145 (22.4)

  Missing

11 (0.1)

4 (0.3)

1 (0.0)

0 (0.0)

2 (0.1)

4 (0.6)

  1. SD standard deviation, ASA American Society of Anesthesiologists